@article{Philip T. Murphy_John Rory O’Donnell_2007, place={Pavia, Italy}, title={Thalidomide induced impotence in male hematology patients: a common but ignored complication?}, volume={92}, url={https://haematologica.org/article/view/4618}, DOI={10.3324/haematol.11095}, abstractNote={Thalidomide has become an important agent in the treatment of myeloma. However, thalidomide induced erectile dysfunction is a serious complication which has received very little attention. In our hematology department, 6 out of 11 male patients developed erectile dysfunction (grade 3 in 5/6) within 4 weeks of starting thalidomide. Our results suggest that thalidomide induced impotence is a common complication in male hematology patients.}, number={10}, journal={Haematologica}, author={Philip T. Murphy and John Rory O’Donnell}, year={2007}, month={Oct.}, pages={1440-1440} }